3B Blackbio Dx Limited (3BBLACKBIO) Share Price
NSE · Healthcare · Biotechnology · ISIN INE994E01018
Key metrics
- Market Cap
- —
- P/E Ratio
- 22.39
- EPS
- 66.39
- Book Value
- 386.41
- P/B Ratio
- 3.88
- ROE
- 17.67%
- ROCE
- 15.43%
- Debt / Equity
- 0.01
- Net Margin
- 41.28%
- Revenue Growth
- 47.11%
- Profit Growth
- 22.95%
- Dividend Yield
- 0.27%
- 52W High
- ₹1,588.90
- 52W Low
- ₹1,099.50
- Market Cap Band
- —
- Face Value
- 10
Ratios computed from the annual results period ending 2026-03-31.
About 3B Blackbio Dx Limited
3B Blackbio Dx Limited engages in the design, development, manufacturing, and commercialization of molecular diagnostic solutions for infectious diseases, oncology, human genetics and antimicrobial resistance in India. The company offers qPCR-based and lateral flow assays rapid tests and Next Gen Sequencing -based molecular diagnostic kits for accurate and reliable testing on patient samples under the TRUPCR, TRUNGS, TRURAPID, brand for testing on patient samples to diagnostics labs. It also offers agrochemical products; technical support and training services. 3B Blackbio Dx Limited was incorporated in 1972 and is headquartered in Bhopal, India.
- Headquarters
- Bhopal, India
- Promoter Holding
- 66.15%
The full 3B Blackbio Dx Limited analysis
Create a free account to open the complete 3BBLACKBIO deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.